ClinicalTrials.Veeva

Menu

Cognitive and Metabolic Effects of a Probiotic Supplement

U

Uppsala University

Status

Unknown

Conditions

Metabolism
Probiotics
Food Preferences
Dietary Supplements
Microbiota

Treatments

Behavioral: Food selection task
Biological: Feces collection
Procedure: Caloric preload
Behavioral: Inhibitory task
Procedure: Blood samples
Behavioral: Food consumption task
Behavioral: Memory task

Study type

Interventional

Funder types

Other

Identifiers

NCT02005003
FF8vsPlaceboJC2013

Details and patient eligibility

About

To examine the cognitive and metabolic effects of a probiotic supplement that is readily and already available for purchase in public drug stores. This study is a double-blinded randomized cross-over placebo-controlled intervention study. Participants will be randomized to receive either the probiotic supplement or the placebo during the first intervention period which will last 2 weeks. This will be followed by a washout period, after which they will proceed to the second intervention period, also lasting 2 weeks and also followed by a washout period.

Enrollment

20 estimated patients

Sex

Male

Ages

18 to 28 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • Age 18-28y
  • Healthy (self-reported) and not on medication
  • Non-smoking
  • Normal sleep-wake rhythm (i.e. 7-8 h per night, self-reported via diaries)
  • Regular meal patterns with daily breakfast

Exclusion criteria

  • Major illness
  • Taking any serious medications
  • Any sleep conditions (e.g. irregular bedtimes, sleep complaints)
  • Any dietary issues with the food items provided
  • Current or history of endocrine, neurological or psychiatric disorders
  • Shift work in the preceding three months or for a long duration
  • Time travel over a significant number of time zones in the preceding two months
  • Too much weight gain or weight loss in the preceding three months
  • Excessive intake of fermented dairy products
  • Intake of probiotics
  • Recent antibiotic treatment (last 6 months)
  • Recent intake of certain dietary supplements
  • Excessive caffeine (>5 cups daily) or alcohol intake (>2 alcohol units daily)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

20 participants in 2 patient groups, including a placebo group

Probiotic
Active Comparator group
Description:
Probiotic pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.
Treatment:
Behavioral: Food consumption task
Behavioral: Food selection task
Biological: Feces collection
Behavioral: Memory task
Procedure: Caloric preload
Behavioral: Inhibitory task
Procedure: Blood samples
Placebo
Placebo Comparator group
Description:
Placebo pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.
Treatment:
Behavioral: Food consumption task
Behavioral: Food selection task
Biological: Feces collection
Behavioral: Memory task
Procedure: Caloric preload
Behavioral: Inhibitory task
Procedure: Blood samples

Trial contacts and locations

1

Loading...

Central trial contact

Jonathan Cedernaes, M.D., PhD; Christian Benedict, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems